At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Blood collection for genetic analysis (genetic)
- How long the study runs
- Study runs about 117 months (dates as stated)
- About the drug or intervention
- Blood collection for genetic analysis — genetic: Blood collection for genetic analysis
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- Not specified
- Who
- All
- Number of participants
- 700
- Started
- 2019-03-12
- Last checked
- 2026-04
Plain English Summary
What is this study?
- • Testing a new treatment for takotsubo cardiomyopathy
- • NA - 700 participants
- • Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences
Who can take part?
- • Adults
- • Diagnosed with takotsubo cardiomyopathy
Where?
- • Aberdeen - Cardiac Research Office, Aberdeen Royal Infirmary
- • Aberdeen - Cardiovascular Research Facility
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.
More detail
Acute stress-induced (takotsubo) cardiomyopathy presents like a myocardial infarct, is triggered by intense emotional or physical stress, and can have catastrophic and potentially fatal consequences. Despite data linking takotsubo cardiomyopathy with conditions that have a recognized genetic predisposition (such as mental health and neurological problems), a systematic and comprehensive characterisation of the genetic-epidemiologic factors in takotsubo is lacking. The researchers propose to further investigate this disorder by collecting blood from probands and characterising the genotype of patients with takotsubo cardiomyopathy in a large scale, nationwide genome wide association study. The investigators will also archive DNA for identification of future candidate genetic variants. Ultimately, understanding the underlying predisposition of this poorly understood neuro-psycho-cardiac disorder is essential if we are to move this field forward.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date.
- ✓Familial cases elsewhere in the world who would be willing to participate.
Who cannot take part
- ✗Unwillingness to participate
See the full criteria
Where Is This Study? (2 UK sites)
Cardiac Research Office, Aberdeen Royal Infirmary
Aberdeen AB25 2ZD, United Kingdom
Cardiovascular Research Facility
Aberdeen AB25 2ZD, United Kingdom
How to Get in Touch
Amelia E Rudd, MSc
Sponsor contactCONTACT
